trump glp 1 medicare The Administration is delivering big news in Medicare! Through the GLP-1 Bridge, eligible beneficiaries can access certain GLP-1 medications for weight management for just a $50 monthly copay. It's a Medicare's new policy to cover
Description
Recent research, notably the pivotal SELECT trial, has confirmed their suitability for non-diabetic subjects with obesity and established CVD
Wegovy, 1%) and nearly one fourth (23%) was for Mounjaro
when it comes to weight loss, these drugs have improved since then is a bit of an understatement: 2) GLP-1 drugs do not allow you to eat whatever you want
doi: 10.1016/j.lanepe.2024.100860
Joseph Schacht, PhD
